FGF23 induces left ventricular hypertrophy.

By C. Faul, A. Amaral, Behzad N. Oskouei, M. Hu, A. Sloan, T. Isakova, O. Gutiérrez, Robier Aguillon-Prada, J. Lincoln, J. Hare and 25 more. Journal of Clinical Investigation, 2011

1,899 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Nephrology

View Paper: https://www.semanticscholar.org/paper/2dbca35ede4fcd9b40741ec4b7bb94ccfafc8a45

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nephrology

1. Harold I. Feldman
2. B. Astor

Citations in the corpus

• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. (2014, background): “Since then, additional strong evidence has emerged in support of this relationship and several nontraditional CKD-specific risk factors for CVD have been identified.(41-43) Despite these findings, patients with CKD remain under-represented in interventional studies and as a consequence, the evidence”